{"disease":{"id":"ocular-toxoplasmosis","name":"ocular toxoplasmosis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03948750","title":"Immunoblotting and Goldmann-Witmer Coefficient for Ocular Toxoplasmosis","phase":"","overall_status":"COMPLETED","enrollment_count":87,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT02863588","title":"Determination of Genetic Susceptibility in Severe Recurrences of Ocular Toxoplasmosis","phase":"NA","overall_status":"TERMINATED","enrollment_count":16,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT04219176","title":"Spectral Optical Coherence Tomography Findings in Patients With Ocular Toxoplasmosis","phase":"","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Université de Sousse","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}